{
    "uniprot_canonical_ac": "A0A0G2JV56-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JV56_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JV56_RAT",
            "type": "external"
        }
    ],
    "mass": 25632.0,
    "length": 230,
    "protein_name": "Ephrin A3",
    "gene_name": "Efna3",
    "organism": "Rat",
    "refseq_name": "ephrin-A3 precursor",
    "refseq_ac": [
        {
            "id": "NP_001414407",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001414407",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Efna3",
    "gene_names_refseq": "Efna3",
    "protein_names_uniprotkb": "Ephrin A3",
    "protein_names_refseq": "ephrin-A3 precursor",
    "tax_id": 10116,
    "disease": "",
    "pathway": " (R-RNO-2682334);  (R-RNO-3928663);  (R-RNO-3928665)",
    "pathway_count": 3,
    "publication_count": 4,
    "publication_id_list": "12077243;32745487;36416239;38009813",
    "function": "Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma., [RefSeq, PubMed]; EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Muller cells in an experimental glaucoma model., [RefSeq, PubMed]; Ephrin A3 is expressed on thymocytes from the subcapsulary region, cortex, and medulla, as well as on epithelial cells of the thymic medulla., [RefSeq, PubMed]; MicroRNA-365 attenuated intervertebral disc degeneration through modulating nucleus pulposus cell apoptosis and extracellular matrix degradation by targeting EFNA3., [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0046875 ephrin receptor binding",
    "go_cellular_component": "GO:0005886 plasma membrane;GO:0098552 side of membrane",
    "go_biological_process": "GO:0048013 ephrin receptor signaling pathway;GO:0045664 regulation of neuron differentiation;GO:0016525 negative regulation of angiogenesis",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JV56-1",
    "record_type": "protein",
    "filter_code": "0000000.0000101.100000.0000000000001000.00000.000"
}